(S)-hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one → (S)-2-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one
반응식
I[C:2]1[CH:3]=[C:4]([CH2:8][CH2:9][N:10]2[CH2:15][CH2:14][N:13]([C:16]3[CH:25]=[CH:24][CH:23]=[C:22]4[C:17]=3[CH:18]=[CH:19][C:20]([CH3:26])=[N:21]4)[CH2:12][CH2:11]2)[CH:5]=[CH:6][CH:7]=1.[CH2:27]1[NH:31][C:30](=[O:32])[N:29]2[CH2:33][CH2:34][CH2:35][C@@H:28]12>>[CH3:26][C:20]1[CH:19]=[CH:18][C:17]2[C:22](=[CH:23][CH:24]=[CH:25][C:16]=2[N:13]2[CH2:14][CH2:15][N:10]([CH2:9][CH2:8][C:4]3[CH:3]=[C:2]([N:31]4[CH2:27][C@@H:28]5[CH2:35][CH2:34][CH2:33][N:29]5[C:30]4=[O:32])[CH:7]=[CH:6][CH:5]=3)[CH2:11][CH2:12]2)[N:21]=1참가 물질
3
실험 절차
The title compound was prepared in 60% yield according to the general procedure for the preparation of the amides, ureas and carbamates (Method A) starting from 5-{4-[2-(3-iodophenyl)ethyl]-1-piperazinyl}-2-methylquinoline and (S)-hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one.
출처 및 근거
- ORD 기록
- ord-fcec45a468a749778425faab002fb1af